Sign in
8-K/A

Current Report

PALVELLA THERAPEUTICS, INC. Filed Acc 0001437749-23-024952

Exit or restructuring costs

  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading pirs20230823c_8ka.htm…